Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
Outset Medical, Inc. updated its 2026 guidance (reaffirmed).
- Period
- 2026
- Guidance
- reaffirmed
- Result
- guidance update
Exact text from the filing
The Company is reiterating previously issued guidance for 2026, and plans to provide additional detail regarding the 2026 financial impact of the Amendment later in the year once it has visibility to the timing and ramp of the implementation.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
Outset Medical, Inc. amended Refresh Amendment with HCA Management Services, L.P. valued at approximately $40 million (effective 2026-06-14).
- Action
- amendment
- Agreement
- supply
- Counterparty
- HCA Management Services, L.P.
- Value
- approximately $40 million
- Effective
- 2026-06-14
Exact text from the filing
On June 14, 2026, Outset Medical, Inc., (the “Company”) entered into the Refresh Amendment (the “Amendment”) to the Purchasing Agreement with HCA Management Services, L.P. (“HCA”), dated May 1, 2020, as amended (collectively, the “Agreement”). Under the terms of the Amendment, the parties have agreed, among other things, for HCA to refresh its existing fleet of Tablo Hemodialysis Systems by purchasing new Tablo Hemodialysis Systems commencing in 2026 through the end of 2028, for an aggregate contract value, net of rebates and allowances, of approximately $40 million.
View on SEC.gov